Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Greenbank Capital | OTC Markets | Finanziario | Servizi bancari e di Investimenti | 1,35 Mln USD | -0,3x | 0,92 | 0,010 USD | -50% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Heliogen | OTC Markets | Energia | Energia rinnovabile | 17,78 Mln USD | -0,1x | 0 | 2,96 USD | -7,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1.213,6% Rialzo | Fai l’upgrade a Pro+ | |
C4 | NASDAQ | Salute | Ricerca medica e biotecnologica | 462,37 Mln USD | -2,8x | -0,26 | 6,68 USD | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 71,6% Rialzo | Fai l’upgrade a Pro+ | |
Digicann Ventures | OTC Markets | Salute | Fornitori e servizi sanitari | 158.999,99 USD | 0x | 0 | 0,02 USD | 110,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ryvyl | NASDAQ | Tecnologia | Software e servizi IT | 12,49 Mln USD | -0,2x | 0,01 | 1,94 USD | -1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Plus Therapeutics | NASDAQ | Salute | Ricerca medica e biotecnologica | 10,35 Mln USD | -0,6x | -0,01 | 1,80 USD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1.066,7% Rialzo | Fai l’upgrade a Pro+ | |
Esperion | NASDAQ | Salute | Prodotti farmaceutici | 413,02 Mln USD | -3,1x | -0,07 | 2,18 USD | -5,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 246,3% Rialzo | Fai l’upgrade a Pro+ | |
Eiger Biopharma | OTC Markets | Salute | Ricerca medica e biotecnologica | 20,73 Mln USD | -0,3x | -0,01 | 14 USD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 114,3% Rialzo | Fai l’upgrade a Pro+ | |
Babcock Wilcox Enterprises | NYSE | Industriali | Macchinari, macchine utensili, mezzi pesanti, treni e navi | 122,87 Mln USD | -1x | 0 | 13,97 USD | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Mustang Bio | NASDAQ | Salute | Ricerca medica e biotecnologica | 11,51 Mln USD | -0,1x | -0,01 | 0,33 USD | -1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 498,8% Rialzo | Fai l’upgrade a Pro+ | |
2Seventy Bio | NASDAQ | Salute | Ricerca medica e biotecnologica | 242,63 Mln USD | -0,9x | -0,06 | 4,28 USD | -9,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 69,5% Rialzo | Fai l’upgrade a Pro+ | |
Solid Biosciences | NASDAQ | Salute | Ricerca medica e biotecnologica | 326,23 Mln USD | -2,3x | -0,07 | 8,64 USD | -3,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 90,6% Rialzo | Fai l’upgrade a Pro+ | |
Redfin | NASDAQ | Immobiliare | Operazioni Immobiliari | 887,67 Mln USD | -6,2x | -0,13 | 7,43 USD | -8,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -7,9% Ribasso | Fai l’upgrade a Pro+ | |
Lemonade | NYSE | Finanziario | Assicurazione | 1,22 Mrd USD | -5,8x | -0,27 | 17,30 USD | -4,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -11,3% Ribasso | Fai l’upgrade a Pro+ | |
HomeStreet | NASDAQ | Finanziario | Servizi bancari | 267,59 Mln USD | -17,8x | 0,04 | 14,20 USD | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 2,4% Rialzo | Fai l’upgrade a Pro+ | |
Qurate Retail B | NASDAQ | Consumi ciclici | Commercio al dettaglio diversificato | 1,58 Mrd USD | -1,6x | -0,02 | 3,92 USD | -1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Oblong | NASDAQ | Tecnologia | Attrezzature e materiali elettronici | 5,03 Mln USD | -0,3x | -0,01 | 0,18 USD | 1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Autolus Therapeutics | NASDAQ | Salute | Ricerca medica e biotecnologica | 1,20 Mrd USD | -3,7x | -0,61 | 4,51 USD | -3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 134,5% Rialzo | Fai l’upgrade a Pro+ | |
Aura Biosciences | NASDAQ | Salute | Ricerca medica e biotecnologica | 505,84 Mln USD | -4x | -1,01 | 9,86 USD | -3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 95,9% Rialzo | Fai l’upgrade a Pro+ | |
Emergent Biosolutions | NYSE | Salute | Prodotti farmaceutici | 545,50 Mln USD | -0,9x | 0,03 | 10,57 USD | -16,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -37,1% Ribasso | Fai l’upgrade a Pro+ | |
Upland Software Inc | NASDAQ | Tecnologia | Software e servizi IT | 62,91 Mln USD | -0,5x | -0,02 | 2,31 USD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8,5% Rialzo | Fai l’upgrade a Pro+ | |
Fangdd Network | NASDAQ | Immobiliare | Operazioni Immobiliari | 2,53 Mln USD | -0,1x | -0 | 0,39 USD | -7,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Design Therapeutics | NASDAQ | Salute | Ricerca medica e biotecnologica | 285,30 Mln USD | -4,8x | -0,32 | 5,05 USD | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -21,6% Ribasso | Fai l’upgrade a Pro+ | |
Koss | NASDAQ | Tecnologia | Computer, telefoni e elettronica per la casa | 84,03 Mln USD | -74,6x | 0,69 | 9,11 USD | -3,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
MeiraGTx | NASDAQ | Salute | Ricerca medica e biotecnologica | 311,89 Mln USD | -3,9x | -0,08 | 4,88 USD | -6,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 148,6% Rialzo | Fai l’upgrade a Pro+ | |
Eos Energy Enterprises | NASDAQ | Industriali | Macchinari, macchine utensili, mezzi pesanti, treni e navi | 392,93 Mln USD | -1,4x | -0,03 | 1,82 USD | -7,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 77,7% Rialzo | Fai l’upgrade a Pro+ | |
Phreesia | NYSE | Tecnologia | Software e servizi IT | 1,41 Mrd USD | -11,3x | -0,4 | 24,61 USD | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,2% Rialzo | Fai l’upgrade a Pro+ | |
Altimmune | NASDAQ | Salute | Ricerca medica e biotecnologica | 431,79 Mln USD | -3,8x | -0,51 | 6,09 USD | -4,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 277,4% Rialzo | Fai l’upgrade a Pro+ | |
BioLife Solutions | NASDAQ | Salute | Attrezzature e forniture medicali | 1,07 Mrd USD | -16,2x | -0,3 | 23,36 USD | -2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8,2% Rialzo | Fai l’upgrade a Pro+ | |
Hovnanian Enterprises | NYSE | Consumi ciclici | Forniture per edilizia e costruzioni | 1,18 Mrd USD | 6,2x | 0,37 | 198,24 USD | -5,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |